← All trials
NCT04896359
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 15, 2019
- Primary completion
- Mar 3, 2021
- Completion date
- Mar 3, 2021
- First posted
- May 21, 2021
- Last posted
- Oct 4, 2021
- Enrollment
- 80
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Universidad San Francisco de QuitoLead sponsor
- Universidad San Francisco de QuitoReponsible party - principal investigator
- Universidad San Francisco de QuitoOverall official - principal investigator
- Biomolec PharmaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.